Basilea reports acceptance for regulatory review of Pfizer’s marketing authorization application for antifungal isavuconazole (Cresemba®) in invasive aspergillosis in China

Adrienne Stevens, EdD
HCP Insights

Bud Bilanich
Success Coach

Sarah Caldwell
Data & Analytics

Julia Laurin
Medication Adherence

Tony Schueth, MS
EHR Strategies

Joe Jackson
Healthcare Engagement Solutions

Brenda Snow
Authentic Patient Voice

Don Feiler
Brand Engagement